Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'

August 25, 2026 6:57 AM

(Updated - August 25, 2026 6:58 AM EDT)

Oppenheimer analyst Leland Gershall upgraded Capricor Therapeutics (NASDAQ: CAPR) from Perform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found